Controlled : Actualité Controlled en direct - P2 | Bourse Reflex
Accueil > Tags > Controlled

  • Toutes les actualités en rapport avec « Controlled »

27/10 17:35 Controlled - 2016 HALF-YEARLY RESULTS: ACCELERATION IN GROWTH CONFIRMED

26/10 19:40 Controlled - ABEO: The final amount of the fund-raising was EUR 22.2 million

19/10 18:00 Controlled - OCEA, DCI and ECA unveil their common solution for MCM operations - risk control and efficiency for Navies

19/10 18:00 Controlled - OCEA, DCI and ECA unveil their common solution for MCM operations - risk control and efficiency for Navies

18/10 11:00 Controlled - ECA Group receives the Innovation Trophy at the Euronaval tradeshow for "STERNA", an application for the UAV IT180 unmanned aerial vehicle (UAV) in the naval defence sector

13/10 18:00 Controlled - Quantum Genomics announces 2016 first-half financial results and first nine months business update

06/10 21:00 Controlled - Resounding success of Initial Public Offering on Euronext Paris

29/09 17:45 Controlled - Quantum Genomics reports positive top-line results from Phase IIa trial of QGC001 in hypertension

27/09 19:00 Controlled - METabolic EXplorer in the 1st half of 2016: Progress in the development of L-Methionine

22/09 18:50 Controlled - 1st Half Year 2016 Results

21/09 17:00 Controlled - PRE-IPO : Launch of AlzProtect's fundraising

06/09 19:00 Controlled - METabolic EXplorer confirms the superior nutritional and economic performance of inoLa(TM): 35% greater nutritional value

06/09 07:00 Controlled - Recording another net profit, FUTUREN demonstrates the strength of its profitability and pursues a sustained growth dynamic

01/08 07:00 Controlled - METabolic EXplorer consults its shareholders concerning the principle of a possible sale of its L-Methionine technology

29/07 18:00 Controlled - Financial results, second quarter 2016

29/07 15:00 Controlled - Artprice: after recovering top position, is China preparing the final attack with Sotheby's - addendum to Artprice's H1 Art Martket report.

26/07 07:00 Controlled - Growth in half-year revenue: +23.0% (vs. H1 2015), driven by a very dynamic Q2 (+ 31.7%)

26/07 07:00 Controlled - Strong growth in revenue in Q2: +33.5%

23/06 17:45 Controlled - GENTICEL REPORTS 18 MONTH INTERIM ANALYSIS OF GTL001 PHASE 2 TRIAL IN HPV16/18 INFECTED WOMEN

21/06 14:15 Controlled - Board of Directors : Proposed reappointments and appointments